Journal of Intensive Care

Journal of Intensive Care is an open access journal launched on 23 October 2013 as the official journal of the Japanese Society of Intensive Care Medicine and published by BMC, covering every branch of intensive care medicine, with a 2025 Journal Impact Factor of 7.5《重症监护杂志》（Journal of Intensive Care）是（Japanese Society of Intensive Care Medicine）的官方期刊，2013 年 10 月 23 日创刊，由（BMC）出版，覆盖重症医学的各个分支，2025 年影响因子为 7.5。

Scope

• Intensive and critical care is the core, including unit organisation, monitoring technology and outcome research in the critically ill重症与危重症监护是核心板块，包括重症单元的组织、监护技术以及危重患者的结局研究。
• Trauma and surgical intensive care are handled as their own stream, reflecting the society's origins in anaesthesia and acute surgery创伤与外科重症监护单列方向，反映该学会在麻醉与急症外科方面的渊源。
• Paediatric intensive care is covered explicitly rather than folded into adult critical care儿科重症监护被明确纳入，而非并入成人重症。
• Acute and emergency medicine, perioperative medicine and resuscitation extend the journal beyond the intensive care unit itself急性与急诊医学、围术期医学与复苏把期刊的范围延伸到重症监护单元之外。
• Infection control and organ dysfunction, including sepsis and acute respiratory distress, are recurring themes感染控制与器官功能障碍，包括脓毒症与急性呼吸窘迫，是反复出现的主题。
• The journal invites work that considers how cultural context shapes intensive care practice, and runs thematic series and society guideline collections期刊欢迎考察文化背景如何塑造重症监护实践的稿件，并组织专题系列与学会指南合集。

History

• The first papers appeared on 23 October 2013, making it the first English-language open access critical care journal published from the Asia-Pacific region首批论文于 2013 年 10 月 23 日上线，该刊因此成为亚太地区第一本重症医学英文开放获取期刊。^[1]
• Satoshi Gando of Hokkaido University was the founding editor-in-chief and set the scope, the publisher relationship and the open access model创刊主编为（Satoshi Gando），任职于（Hokkaido University），确定了办刊范围、出版方关系与开放获取模式。
• Hiroshi Morisaki took over in 2018 and rebuilt the board, when submissions reached 341 a year and more than three quarters came from outside Japan（Hiroshi Morisaki）于 2018 年接任并重组编委会，当时年投稿量为 341 篇，逾四分之三来自日本以外。^[2]
• The journal entered the Emerging Sources Citation Index in 2017, was accepted into SCIE at the end of 2019, and received a first impact factor of 3.103 in 2020期刊于 2017 年进入新兴来源引文索引，2019 年底被（SCIE）收录，2020 年公布的首个影响因子为 3.103。
• The society subsidises the article processing charge, covering 40 percent for authors in 2025, although the support was tightened for 2026学会对文章处理费给予补贴，2025 年为作者承担四成，2026 年起资助力度收紧。
• Its impact factor moved from 3.953 in 2021 to 7.52 in 2022, 4.7 in 2024 and 7.5 in 2025影响因子由 2021 年的 3.953 升至 2022 年的 7.52，2024 年为 4.7，2025 年为 7.5。

Editors

• Takeshi Suzuki of Tokai University School of Medicine is editor-in-chief, and also directs the intensive care unit at Tokai University Hospital现任主编为（Takeshi Suzuki），任职于（Tokai University School of Medicine），并兼任（Tokai University Hospital）重症监护单元主任。
• Moritoki Egi, Nobuaki Shime and Tomoaki Yatabe serve as deputy editors, based at Kyoto University, Hiroshima University and Nishichita General Hospital respectively副主编为（Moritoki Egi）、（Nobuaki Shime）与（Tomoaki Yatabe），分别任职于（Kyoto University）、（Hiroshima University）与（Nishichita General Hospital）。
• Satoshi Gando and Hiroshi Morisaki continue as senior editors, the latter at Keio University School of Medicine（Satoshi Gando）与（Hiroshi Morisaki）继续担任高级编辑，后者任职于（Keio University School of Medicine）。
• The advisory board includes Yaseen Arabi, Jan Bakker, Jigeeshu Divatia, Younsuck Koh, Jeffrey Lipman, John Marshall, Jason Phua and Jean-Louis Vincent顾问委员会包括（Yaseen Arabi）、（Jan Bakker）、（Jigeeshu Divatia）、（Younsuck Koh）、（Jeffrey Lipman）、（John Marshall）、（Jason Phua）与（Jean-Louis Vincent）。
• Review follows a traditional closed model with at least two reviewers for every manuscript that reaches review, and the office tracks turnaround closely期刊沿用传统封闭式评议，每篇进入评审的稿件至少送两位评审，编辑部对审稿周期密切跟踪。
• In 2019 the median time to first and final decision was 13 and 24 days respectively, a performance the journal still cites as a selling point2019 年初审与终审中位时间分别为 13 天与 24 天，这一表现至今仍被期刊作为办刊优势提及。